A detailed history of Sunbeam Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sunbeam Capital Management, LLC holds 4,449 shares of ABBV stock, worth $1.04 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
4,449
Previous 4,244 4.83%
Holding current value
$1.04 Million
Previous $788 Million 30.76%
% of portfolio
0.64%
Previous 0.6%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$184.85 - $231.54 $37,894 - $47,465
205 Added 4.83%
4,449 $1.03 Billion
Q2 2025

Jul 23, 2025

BUY
$170.16 - $206.27 $42,199 - $51,154
248 Added 6.21%
4,244 $788 Million
Q1 2025

May 06, 2025

BUY
$169.2 - $216.66 $17,596 - $22,532
104 Added 2.67%
3,996 $837 Million
Q4 2024

Feb 24, 2025

BUY
$164.99 - $203.87 $35,307 - $43,628
214 Added 5.82%
3,892 $692 Million
Q4 2024

Feb 20, 2025

BUY
$164.99 - $203.87 $606,833 - $749,833
3,678 New
3,678 $692 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sunbeam Capital Management, LLC Portfolio

Follow Sunbeam Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbeam Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sunbeam Capital Management, LLC with notifications on news.